Tracy Young1,2,3, Om-Alkhir Alshanta1,3, Ryan Kean3,4, David Bradshaw5, Jonathan Pratten5, Craig Williams3,6, Chris Woodall2, Gordon Ramage1,3, Jason L Brown1,3. 1. School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, Glasgow University, Glasgow G12 8QQ, UK. 2. Blutest Laboratories, 5 Robroyston Oval, Nova Business Park, Glasgow G33 1AP, UK. 3. Glasgow Biofilm Research Network, 378 Sauchiehall Street, Glasgow G2 3JZ, UK. 4. Department of Biological and Biomedical Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow G4 0BA, UK. 5. Oral Healthcare R&D, GlaxoSmithKline Consumer Healthcare, Weybridge KT13 0DE, UK. 6. Microbiology Department, Lancaster Royal Infirmary, University of Lancaster, Lancaster LA1 4YW, UK.
Abstract
Background: Existing standardized biofilm assays focus on simple mono-species or bacterial-only models. Incorporating Candida albicans into complex biofilm models can offer a more appropriate and relevant polymicrobial biofilm for the development of oral health products. Aims: This study aimed to assess the importance of interkingdom interactions in polymicrobial oral biofilm systems with or without C. albicans, and test how these models respond to oral therapeutic challenges in vitro. Materials and Methods: Polymicrobial biofilms (two models containing 5 and 10 bacterial species, respectively) were created in parallel in the presence and absence of C. albicans and challenged using clinically relevant antimicrobials. The metabolic profiles and biomasses of these complex biofilms were estimated using resazurin dye and crystal violet stain, respectively. Quantitative PCR was utilized to assess compositional changes in microbial load. Additional assays, for measurements of pH and lactate, were included to monitor fluctuations in virulence "biomarkers." Results: An increased level of metabolic activity and biomass in the presence of C. albicans was observed. Bacterial load was increased by more than a factor of 10 in the presence of C. albicans. Assays showed inclusion of C. albicans impacted the biofilm virulence profiles. C. albicans did not affect the biofilms' responses to the short-term incubations with different treatments. Conclusions: The interkingdom biofilms described herein are structurally robust and exhibit all the hallmarks of a reproducible model. To our knowledge, these data are the first to test the hypothesis that yeasts may act as potential "keystone" components of oral biofilms.
Background: Existing standardized biofilm assays focus on simple mono-species or bacterial-only models. Incorporating Candida albicans into complex biofilm models can offer a more appropriate and relevant polymicrobial biofilm for the development of oral health products. Aims: This study aimed to assess the importance of interkingdom interactions in polymicrobial oral biofilm systems with or without C. albicans, and test how these models respond to oral therapeutic challenges in vitro. Materials and Methods: Polymicrobial biofilms (two models containing 5 and 10 bacterial species, respectively) were created in parallel in the presence and absence of C. albicans and challenged using clinically relevant antimicrobials. The metabolic profiles and biomasses of these complex biofilms were estimated using resazurin dye and crystal violet stain, respectively. Quantitative PCR was utilized to assess compositional changes in microbial load. Additional assays, for measurements of pH and lactate, were included to monitor fluctuations in virulence "biomarkers." Results: An increased level of metabolic activity and biomass in the presence of C. albicans was observed. Bacterial load was increased by more than a factor of 10 in the presence of C. albicans. Assays showed inclusion of C. albicans impacted the biofilm virulence profiles. C. albicans did not affect the biofilms' responses to the short-term incubations with different treatments. Conclusions: The interkingdom biofilms described herein are structurally robust and exhibit all the hallmarks of a reproducible model. To our knowledge, these data are the first to test the hypothesis that yeasts may act as potential "keystone" components of oral biofilms.
Authors: Indira M G Cavalcanti; Angela H Nobbs; Antônio Pedro Ricomini-Filho; Howard F Jenkinson; Altair A Del Bel Cury Journal: Pathog Dis Date: 2016-01-10 Impact factor: 3.166
Authors: Lindsay E O'Donnell; Emma Millhouse; Leighann Sherry; Ryan Kean; Jennifer Malcolm; Christopher J Nile; Gordon Ramage Journal: FEMS Yeast Res Date: 2015-08-21 Impact factor: 2.796
Authors: Slavena Vylkova; Aaron J Carman; Heather A Danhof; John R Collette; Huaijin Zhou; Michael C Lorenz Journal: mBio Date: 2011-05-17 Impact factor: 7.867
Authors: Yujie Zhou; Suping Wang; Xuedong Zhou; Yiran Zou; Mingyun Li; Xian Peng; Biao Ren; Hockin H K Xu; Michael D Weir; Lei Cheng; Yu Chen; Qi Han Journal: Biomed Res Int Date: 2019-01-21 Impact factor: 3.411
Authors: Laís Salomão Arias; Jason L Brown; Mark C Butcher; Christopher Delaney; Douglas Roberto Monteiro; Gordon Ramage Journal: J Oral Microbiol Date: 2020-06-07 Impact factor: 5.474
Authors: Bryn Short; Christopher Delaney; Emily McKloud; Jason L Brown; Ryan Kean; Gary J Litherland; Craig Williams; S Lorraine Martin; William G MacKay; Gordon Ramage Journal: Front Cell Infect Microbiol Date: 2021-11-23 Impact factor: 5.293
Authors: Dolunay Gülmez; Jason L Brown; Mark C Butcher; Christopher Delaney; Ryan Kean; Gordon Ramage; Bryn Short Journal: Antibiotics (Basel) Date: 2022-07-11
Authors: Hafsa Abduljalil; Ahmed Bakri; Khawlah Albashaireh; Om Alkhir Alshanta; Jason L Brown; Leighann Sherry; Ryan Kean; Christopher Nile; William McLean; Gordon Ramage Journal: APMIS Date: 2022-07-20 Impact factor: 3.428
Authors: Jason L Brown; Tracy Young; Emily McKloud; Mark C Butcher; David Bradshaw; Jonathan R Pratten; Gordon Ramage Journal: Antibiotics (Basel) Date: 2022-01-16
Authors: Man Kit Cheung; Jason Y K Chan; Martin C S Wong; Po Yee Wong; Pu Lei; Liuyang Cai; Linlin Lan; Wendy C S Ho; Apple C M Yeung; Paul K S Chan; Zigui Chen Journal: Microbiol Spectr Date: 2022-02-02